L3402016EN7210120161215EN0009721721<p xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">Corrigendum to Commission Regulation (EU) 2016/1015 of 17 June 2016 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for 1 naphthylacetamide, 1-naphthylacetic acid, chloridazon, fluazifop-P, fuberidazole, mepiquat and tralkoxydim in or on certain products</p>
<p xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">(Official Journal of the European Union L 172 of 29 June 2016)</p>On page 21, in point (2) of the Annex:<p xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><!--default P | TXT -->for:</p>
<mod xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
   <quotedStructure startQuote="" endQuote="">
      <point>
         <num>&apos;(2)</num>
         <p>In Annex III in Part B, the columns for 1-naphthylacetamide, 1-naphthylacetic acid, chloridazon, fluazifop-P, fuberidazole, mepiquat and tralkoxydim are deleted.&apos;</p>
      </point>
   </quotedStructure>
</mod>
<p xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><!--default P | TXT -->read:</p>
<mod xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
   <quotedStructure startQuote="" endQuote="">
      <point>
         <num>&apos;(2)</num>
         <p>In Annex III in Part A, the columns for 1-naphthylacetamide, 1-naphthylacetic acid, chloridazon, fluazifop-P, fuberidazole, mepiquat and tralkoxydim are deleted.&apos;</p>
      </point>
   </quotedStructure>
</mod>
